As director of innovation programs for the University of Chicago's Polsky Center For Entrepreneurship and Innovation, Melissa oversees the cross-campus entrepreneurship initiatives—including the NSF-funded I-Corps Program and the Collaboratorium—which cater to diverse audiences of graduate students, post-docs, undergraduates, and faculty. Melissa works on aligning Polsky’s current portfolio of educational offerings to scientific and technical audiences and identifying areas for strategic growth. Melissa spent 10 years working in clinical research operations and regulatory compliance at the University of Chicago and the University of Pennsylvania, most recently as a director in the UChicago Biological Sciences Division’s Office of Clinical Research. In addition to her work in clinical research, Melissa is also the founder and CEO of Foresee Analytica, and participated in the Polsky I-Corps, Edward L. Kaplan, ’71, New Venture Challenge, and George Shultz Innovation Fund. FORESEEaBILL, the company’s initial product, is a platform technology that provides life sciences organizations with decision support to identify the appropriate payer for every test, procedure, and service performed during a clinical trial. Melissa holds a Master of Biomedical Ethics and Health Policy from the University of Pennsylvania and a Master of Science in Biomedical Informatics from the University of Chicago.